HOME › DRUGS › INTERFERON ALFA-2B
ACTIVE SUBSTANCE / INN

INTERFERON ALFA-2B

Brand name(s): Viraferon, INTRON A, IntronA
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
Hepatitis C, Chronic;Hepatitis B, Chronic
BLA103132
ACTIVE SUBSTANCE
Interferon Alfa-2B
REGULATORS
FDA · EMA
SPONSORS / MAH
SCHERING, Merck Sharp & Dohme B.V., Schering-Plough Europe
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INTRON ABLA103132SCHERINGPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
IntronAMerck Sharp & Dohme B.V.Withdrawn09/03/2000Carcinoid Tumor;Leukemia, Hairy Cell;Lymphoma, Follicular;Hepatitis B, Chronic;H…
ViraferonSchering-Plough EuropeWithdrawn09/03/2000Hepatitis C, Chronic;Hepatitis B, Chronic

FULL INTELLIGENCE ON INTERFERON ALFA-2B

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →